Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group.
By G. Bakris, Mark B. Williams, L. Dworkin, W. Elliott, Murray Epstein, R. Toto, K. Tuttle, J. Douglas, Willa A. Hsueh, J. Sowers. American Journal of Kidney Diseases, 2000
1,273 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Nephrology
View Paper: https://www.semanticscholar.org/paper/e448746cc0a933fd8c5ac5b80a3291bf1d4758fc
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
In Endocrinology, Diabetes and Metabolism
Citations in the corpus
- American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. (2007, neutral): “50% insulin lispro protamine suspension/50% insulin lispro injection (Humalog Mix 50/50) (4) 5-15 min Dual 10-16 h”
- The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. (2003, background): “In patients with chronic kidney disease, defined by either (1) reduced excretory function with an estimated glomerular filtration rate of less than 60 mL/min per 1.73 m2 (corresponding approximately to a creatinine of 1.5 mg/dL [ 132.6 µmol/L] in men or 1.3 mg/dL [ 114.9 µmol/L] in women)20 or (2) t”
- Standards of Medical Care in Diabetes—2008 (2008, background): “In addition, large prospective randomized studies in patients with type 1 diabetes have demonstrated that achievement of lower levels of systolic blood pressure ( 140 mmHg) resulting from treatment using ACE inhibitors provides a selective benefit over other antihypertensive drug classes in delaying”